Inve India ▾

Rainbow Childrens Medicare share price & results

Rainbow Childrens Medicare Limited· Healthcare

Results to
Jun 2026
Latest analysed call
Q1 FY27
Ownership as of
Sept 2026

India's largest pediatric hospital chain, running children's, maternity & fertility hospitals nationwide.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue470 ₹ crore+33.1% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin29.0 %0.0 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit63.0 ₹ crore+16.7% YoYQuarterly, as filedQuarter to Jun 2026Profit after tax as filed.
Return on equity18.47 %−1.4 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin12.04 %−4.5 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)18.34 %−4.6 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Guidance

What management said, and what became of it

4 of 13 judged targets kept · 18 open · verdicts reflect calls analysed to Q1 FY27.

Rainbow Childrens Medicare Limited management guidance track record on Inve: 31 targets tracked across analysed earnings calls (4 achieved, 9 missed, 18 open).

TargetOriginal wordingSaidLatest callVerdict
Annual Revenue Growth FY2620% for FY26
Call transcript, Q1 FY26 · 28 Jul 2025		Q1 FY26Q1 FY27:Historical promise for FY26. No new update.
Call transcript, Q1 FY27 · 31 Jul 2026		Achieved*
International Revenue Mixat least 10% in next 5 years
Call transcript, Q2 FY26 · 14 Nov 2025		Q2 FY26Q1 FY27:The international business was not mentioned in the earnings call or presentation, despite being a key concern in the previous quarter.
Call transcript, Q1 FY27 · 31 Jul 2026		Ghosted
Revenue CAGR18-20% over Next 3-5 years
Call transcript, Q4 FY25 · 26 May 2025		Q4 FY25Q1 FY27:Management stated, 'If we are able to sustain revenue growth of around 20% annually, that would naturally result in the business doubling its revenue over approximately four years.' This brings guidance back in line with the original 18-20% target.
Call transcript, Q1 FY27 · 31 Jul 2026		Revised Up

Source: Inve Guidance Tracker for Rainbow Childrens Medicare Limited · to Q1 FY27

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

9 of Rainbow Childrens Medicare Limited's 31 targets were missed. See which ones, and which are quietly gone. The 3 above are the free sample; 28 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹1,162 −0.65% · −₹7.6

Last close 26 Oct 2026 · NSE · INR · Source: Inve

Performance −14.9% 1Y

₹1.2k₹1.4k₹1.6kOct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26Q2 FY26 — 14 Nov 2025Q3 FY26 — 29 Jan 2026Q4 FY26 — 25 May 2026Q1 FY27 — 31 Jul 2026

1Y: ₹1,365 on 24 Oct 2025 → ₹1,162. High ₹1,598.6 (5 Aug 2026), low ₹1,103.8 (19 Mar 2026).

Previous close
₹1,169.6
Market cap
₹11.8k Cr
52-week range
₹1,103.8 – ₹1,598.6
One year
−14.55%
Price to earnings (TTM to Jun 2026)
40.98×
Return on equity (TTM to Jun 2026)
18.47%

Overview

Symbol
NSE:RAINBOW
Exchange
NSE
Currency
INR

What Rainbow Childrens Medicare Limited does

Based on the company's own presentations, annual report and earnings calls.

Rainbow Children's Medicare operates a chain of standalone, purpose-built children's hospitals delivering pediatric multi-specialty and quaternary care (including neonatal and pediatric intensive care), alongside obstetrics, gynaecology and fertility services under its BirthRight brand. It earns primarily from inpatient and outpatient care, deliveries and fertility treatments across its owned hospital network, following a hub-and-spoke model where larger flagship hub hospitals anchor super-specialty and critical care while smaller spoke hospitals extend reach into surrounding towns and cities. The company also treats international patients, mainly referred from South Asian, Middle Eastern and African markets, and runs an accredited pediatric physician training program.

Segments

  • Pediatric Care
  • Obstetrics & Gynaecology (BirthRight)
  • Fertility (BirthRight Fertility)
Hospitals
24
Total beds
2,435
Cities with presence
9
Full-time doctors
1,050+
Standalone clinics
5
Fertility (IVF) centres
2 IVF centers & 1 clinic
Founded 1999Headquarters Hyderabad, Telangana, India Company website

How the price took the results

close before → close after

Q1 FY27
+0.3%
31 Jul
Q4 FY26
−0.4%
25 May
Q3 FY26
−0.3%
29 Jan
Q2 FY26
−1.0%
14 Nov

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Your own record

Start an Inve Case for Rainbow Childrens Medicare Limited

Free account: one company. Everything above stays public.

Write why you follow Rainbow Childrens Medicare Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Healthcare companies

All Healthcare companies → · Healthcare earnings growth →

Learn to analyse Rainbow Childrens Medicare Limited

Guides on how to read this kind of business and the numbers that matter.